Apnimed Rises On Its Public Debut As More Drug Developers Prepare IPO Launches Scrip Pharma Intelligence 01:44 Sat, 01 Aug
With sleep apnea drug under review, Apnimed prices $192M IPO BioWorld 20:30 Fri, 31 Jul Article paywall
Could 1 tiny biotech topple Vertex Pharmaceuticals' cystic fibrosis empire? The Motley Fool 3d Vertex Pharmaceuticals All sources
Are Wall Street analysts predicting Moderna stock will climb or sink? Barchart 5d Moderna Vaccine Coronavirus Vaccine Wall Street All sources
Fermenta Biotech shares make debut on NSE The Hindu Business Line 6d Fermenta Biotech India Stock Markets (India) All sources
Bengaluru to lead India’s deep-tech revolution, says D K Shivakumar The Hindu Business Line 6d Chemistry India AI All sources
